Proteins > Transient receptor potential cation channel subfamily V member 1
Page last updated: 2024-08-07 17:19:17
Transient receptor potential cation channel subfamily V member 1
A transient receptor potential cation channel TRPV1 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q8NER1]
Synonyms
TrpV1;
Capsaicin receptor;
Osm-9-like TRP channel 1;
OTRPC1;
Vanilloid receptor 1
Research
Bioassay Publications (82)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.22) | 18.2507 |
2000's | 30 (36.59) | 29.6817 |
2010's | 40 (48.78) | 24.3611 |
2020's | 11 (13.41) | 2.80 |
Compounds (68)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
2-aminoethoxydiphenyl borate | Homo sapiens (human) | Activity | 10.0000 | 1 | 1 |
citronellol | Homo sapiens (human) | Activity | 43.0000 | 1 | 1 |
allicin | Homo sapiens (human) | Activity | 0.0990 | 1 | 1 |
voacamine | Homo sapiens (human) | Kb | 18.0000 | 1 | 1 |
geraniol | Homo sapiens (human) | Activity | 102.0000 | 1 | 1 |
piperine | Homo sapiens (human) | Activity | 10.0000 | 1 | 1 |
capsaicin | Homo sapiens (human) | Activity | 0.0100 | 1 | 1 |
anandamide | Homo sapiens (human) | Activity | 1.0000 | 1 | 1 |
olvanil | Homo sapiens (human) | Activity | 0.0100 | 1 | 1 |
Phytocannabinoid Pharmacology: Medicinal Properties of Journal of natural products, , 01-22, Volume: 84, Issue:1, 2021
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.Journal of natural products, , 03-23, Volume: 81, Issue:3, 2018
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.Journal of natural products, , Aug-22, Volume: 77, Issue:8, 2014
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.Journal of natural products, , Feb-28, Volume: 77, Issue:2, 2014
Arylboronic acids as dual-action FAAH and TRPV1 ligands.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 26, Issue:5, 2016
Discovery of small molecule antagonists of TRPV1.Bioorganic & medicinal chemistry letters, , Jul-16, Volume: 14, Issue:14, 2004
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.Journal of medicinal chemistry, , May-31, Volume: 50, Issue:11, 2007
Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.Journal of medicinal chemistry, , Jul-26, Volume: 50, Issue:15, 2007
Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
[no title available]Journal of medicinal chemistry, , 09-08, Volume: 65, Issue:17, 2022
Discovery of Benzopyridone-Based Transient Receptor Potential Vanilloid 1 Agonists and Antagonists and the Structural Elucidation of Their Activity Shift.Journal of medicinal chemistry, , 01-14, Volume: 64, Issue:1, 2021
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Discovery of a Remarkable Methyl Shift Effect in the Vanilloid Activity of Triterpene Amides.Journal of natural products, , 11-25, Volume: 83, Issue:11, 2020
Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical Analgesic.Journal of medicinal chemistry, , 01-09, Volume: 63, Issue:1, 2020
[no title available]Bioorganic & medicinal chemistry, , 07-01, Volume: 27, Issue:13, 2019
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders.Journal of medicinal chemistry, , 05-24, Volume: 61, Issue:10, 2018
Analyses of Synthetic N-Acyl Dopamine Derivatives Revealing Different Structural Requirements for Their Anti-inflammatory and Transient-Receptor-Potential-Channel-of-the-Vanilloid-Receptor-Subfamily-Subtype-1 (TRPV1)-Activating Properties.Journal of medicinal chemistry, , 04-12, Volume: 61, Issue:7, 2018
Novel Radiolabeled Vanilloid with Enhanced Specificity for Human Transient Receptor Potential Vanilloid 1 (TRPV1).Journal of medicinal chemistry, , 10-12, Volume: 60, Issue:19, 2017
Discovery of non-electrophilic capsaicinoid-type TRPA1 ligands.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 25, Issue:5, 2015
Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 22, Issue:4, 2012
In vitro TRPV1 activity of piperine derived amides.Bioorganic & medicinal chemistry, , May-01, Volume: 18, Issue:9, 2010
Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 20, Issue:23, 2010
Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): The side chain benzylic methylene.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 20, Issue:1, 2010
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): the homovanillyl moiety.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 17, Issue:1, 2007
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.The Journal of pharmacology and experimental therapeutics, , Volume: 323, Issue:1, 2007
Sensing with TRP channels.Nature chemical biology, , Volume: 1, Issue:2, 2005
N-Acylvanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor.Journal of medicinal chemistry, , Aug-15, Volume: 45, Issue:17, 2002
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.Journal of natural products, , Aug-22, Volume: 77, Issue:8, 2014
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.Journal of natural products, , Feb-28, Volume: 77, Issue:2, 2014
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.Bioorganic & medicinal chemistry, , Nov-01, Volume: 21, Issue:21, 2013
In vitro TRPV1 activity of piperine derived amides.Bioorganic & medicinal chemistry, , May-01, Volume: 18, Issue:9, 2010
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.The Journal of pharmacology and experimental therapeutics, , Volume: 323, Issue:1, 2007
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.Journal of medicinal chemistry, , May-31, Volume: 50, Issue:11, 2007
Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain.Journal of medicinal chemistry, , Jan-26, Volume: 49, Issue:2, 2006
Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides.Journal of medicinal chemistry, , Jan-13, Volume: 48, Issue:1, 2005
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.Journal of medicinal chemistry, , Mar-24, Volume: 48, Issue:6, 2005
The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination.Journal of medicinal chemistry, , Jul-14, Volume: 48, Issue:14, 2005
7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1.Bioorganic & medicinal chemistry letters, , Jan-19, Volume: 14, Issue:2, 2004
N-isoquinolin-5-yl-N'-aralkyl-urea and -amide antagonists of human vanilloid receptor 1.Bioorganic & medicinal chemistry letters, , Jun-21, Volume: 14, Issue:12, 2004
Discovery of small molecule antagonists of TRPV1.Bioorganic & medicinal chemistry letters, , Jul-16, Volume: 14, Issue:14, 2004
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.Journal of medicinal chemistry, , Nov-14, Volume: 56, Issue:21, 2013
Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased neuropeptide Y (NPY).Journal of medicinal chemistry, , Mar-14, Volume: 56, Issue:5, 2013
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity.Journal of medicinal chemistry, , Apr-06, Volume: 49, Issue:7, 2006
Sensing with TRP channels.Nature chemical biology, , Volume: 1, Issue:2, 2005
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.Journal of medicinal chemistry, , Nov-14, Volume: 56, Issue:21, 2013
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.The Journal of pharmacology and experimental therapeutics, , Volume: 323, Issue:1, 2007
Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased neuropeptide Y (NPY).Journal of medicinal chemistry, , Mar-14, Volume: 56, Issue:5, 2013
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity.Journal of medicinal chemistry, , Apr-06, Volume: 49, Issue:7, 2006
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.The Journal of pharmacology and experimental therapeutics, , Volume: 323, Issue:1, 2007
Sensing with TRP channels.Nature chemical biology, , Volume: 1, Issue:2, 2005
N-Acylvanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor.Journal of medicinal chemistry, , Aug-15, Volume: 45, Issue:17, 2002
Phytocannabinoid Pharmacology: Medicinal Properties of Journal of natural products, , 01-22, Volume: 84, Issue:1, 2021
Bioactive prenylogous cannabinoid from fiber hemp (Cannabis sativa).Journal of natural products, , Sep-23, Volume: 74, Issue:9, 2011
Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 24, Issue:1, 2014
The carbonate analogues of 5'-halogenated resiniferatoxin as TRPV1 ligands.European journal of medicinal chemistry, , Volume: 68, 2013
Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): The side chain benzylic methylene.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 20, Issue:1, 2010
6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonists.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 25, Issue:4, 2015
Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists.Bioorganic & medicinal chemistry letters, , Mar-01, Volume: 21, Issue:5, 2011
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.Journal of medicinal chemistry, , Feb-14, Volume: 51, Issue:3, 2008
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.The Journal of pharmacology and experimental therapeutics, , Volume: 323, Issue:1, 2007
In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists.Journal of medicinal chemistry, , Jul-26, Volume: 50, Issue:15, 2007
Alpha-methylation at benzylic fragment of N-aryl-N'-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 17, Issue:14, 2007
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.Journal of medicinal chemistry, , May-31, Volume: 50, Issue:11, 2007
Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.Journal of medicinal chemistry, , Feb-10, Volume: 48, Issue:3, 2005
N-isoquinolin-5-yl-N'-aralkyl-urea and -amide antagonists of human vanilloid receptor 1.Bioorganic & medicinal chemistry letters, , Jun-21, Volume: 14, Issue:12, 2004
Discovery of (S)-N-(3-isopropylphenyl)-2-(5-phenylthiazol-2-yl)pyrrolidine-1-carboxamide as potent and brain-penetrant TRPV1 antagonist.European journal of medicinal chemistry, , Apr-05, Volume: 233, 2022
Design, synthesis, and biological evaluation of novel biphenyl-4-carboxamide derivatives as orally available TRPV1 antagonists.Bioorganic & medicinal chemistry, , 07-23, Volume: 26, Issue:12, 2018
Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 16, Issue:12, 2006
Discovery of Benzopyridone-Based Transient Receptor Potential Vanilloid 1 Agonists and Antagonists and the Structural Elucidation of Their Activity Shift.Journal of medicinal chemistry, , 01-14, Volume: 64, Issue:1, 2021
Study on chemical modification and analgesic activity of N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxamide.European journal of medicinal chemistry, , May-15, Volume: 194, 2020
Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists.European journal of medicinal chemistry, , Sep-15, Volume: 178, 2019
Novel benzodiazepines derivatives as analgesic modulating for Transient receptor potential vanilloid 1.Bioorganic & medicinal chemistry, , 08-15, Volume: 26, Issue:15, 2018
Design, synthesis, and biological evaluation of novel biphenyl-4-carboxamide derivatives as orally available TRPV1 antagonists.Bioorganic & medicinal chemistry, , 07-23, Volume: 26, Issue:12, 2018
Phenylquinoline transient receptor potential vanilloid 1 antagonists for the treatment of pain: Discovery of 1-(2-phenylquinoline-4-carbonyl)-N-(4-(trifluoromethyl)phenyl)pyrrolidine-3-carboxamide.Bioorganic & medicinal chemistry, , 02-15, Volume: 26, Issue:4, 2018
Pharmacological evaluation of novel (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives as TRPV4 antagonists for the treatment of pain.Bioorganic & medicinal chemistry, , 04-01, Volume: 25, Issue:7, 2017
Novel Radiolabeled Vanilloid with Enhanced Specificity for Human Transient Receptor Potential Vanilloid 1 (TRPV1).Journal of medicinal chemistry, , 10-12, Volume: 60, Issue:19, 2017
Design, synthesis and biological evaluation of novel analgesic agents targeting both cyclooxygenase and TRPV1.Bioorganic & medicinal chemistry, , Feb-15, Volume: 24, Issue:4, 2016
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives.Journal of natural products, , Aug-22, Volume: 77, Issue:8, 2014
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.Journal of natural products, , Feb-28, Volume: 77, Issue:2, 2014
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.Bioorganic & medicinal chemistry, , Nov-01, Volume: 21, Issue:21, 2013
Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 19, Issue:23, 2009
Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.Bioorganic & medicinal chemistry, , Sep-15, Volume: 16, Issue:18, 2008
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.Journal of medicinal chemistry, , May-31, Volume: 50, Issue:11, 2007
Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 14, Issue:22, 2004
Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 24, Issue:24, 2014
New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain.Journal of medicinal chemistry, , Dec-27, Volume: 50, Issue:26, 2007
2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.Journal of medicinal chemistry, , Oct-11, Volume: 55, Issue:19, 2012
Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents.Journal of medicinal chemistry, , Sep-08, Volume: 48, Issue:18, 2005
Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl)methyl) ureas as potent and thermoneutral TRPV1 antagonists.Bioorganic & medicinal chemistry letters, , 12-01, Volume: 30, Issue:23, 2020
Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacy.Journal of medicinal chemistry, , Sep-11, Volume: 57, Issue:17, 2014
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.Journal of medicinal chemistry, , Apr-22, Volume: 53, Issue:8, 2010
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.Journal of medicinal chemistry, , Feb-14, Volume: 51, Issue:3, 2008
Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 20, Issue:23, 2010
The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.Journal of medicinal chemistry, , May-31, Volume: 50, Issue:11, 2007
Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.Bioorganic & medicinal chemistry, , Sep-15, Volume: 16, Issue:18, 2008
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.The Journal of pharmacology and experimental therapeutics, , Volume: 323, Issue:1, 2007
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.Bioorganic & medicinal chemistry, , 02-15, Volume: 56, 2022
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.Journal of medicinal chemistry, , Apr-22, Volume: 53, Issue:8, 2010
4-Aminopyrimidine tetrahydronaphthols: a series of novel vanilloid receptor-1 antagonists with improved solubility properties.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 18, Issue:6, 2008
Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.Journal of medicinal chemistry, , May-08, Volume: 51, Issue:9, 2008
Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.Journal of medicinal chemistry, , Jul-26, Volume: 50, Issue:15, 2007
Enables
This protein enables 15 target(s):
Target | Category | Definition |
transmembrane signaling receptor activity | molecular function | Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction. [GOC:go_curators, Wikipedia:Transmembrane_receptor] |
extracellular ligand-gated monoatomic ion channel activity | molecular function | Enables the transmembrane transfer of an ion by a channel that opens when a specific extracellular ligand has been bound by the channel complex or one of its constituent parts. [GOC:mtg_transport, ISBN:0815340729] |
excitatory extracellular ligand-gated monoatomic ion channel activity | molecular function | Enables the transmembrane transfer of an ion by a channel that opens when a specific extracellular ligand has been bound by the channel complex or one of its constituent parts, where channel opening contributes to an increase in membrane potential. [GOC:mah, ISBN:0323037070] |
voltage-gated calcium channel activity | molecular function | Enables the transmembrane transfer of a calcium ion by a voltage-gated channel. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded. [GOC:mtg_transport, GOC:tb, ISBN:0815340729] |
calcium channel activity | molecular function | Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism. [GOC:mtg_transport, GOC:pr, ISBN:0815340729] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
calmodulin binding | molecular function | Binding to calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states. [GOC:krc] |
ATP binding | molecular function | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. [ISBN:0198506732] |
intracellularly gated calcium channel activity | molecular function | Enables the transmembrane transfer of a calcium ion by a channel that opens when a specific intracellular ligand has been bound by the channel complex or one of its constituent parts. [GOC:mah] |
chloride channel regulator activity | molecular function | Binds to and modulates the activity of a chloride channel. [GOC:mah] |
phosphatidylinositol binding | molecular function | Binding to an inositol-containing glycerophospholipid, i.e. phosphatidylinositol (PtdIns) and its phosphorylated derivatives. [GOC:bf, ISBN:0198506732, PMID:11395417] |
identical protein binding | molecular function | Binding to an identical protein or proteins. [GOC:jl] |
metal ion binding | molecular function | Binding to a metal ion. [GOC:ai] |
phosphoprotein binding | molecular function | Binding to a phosphorylated protein. [GOC:ai] |
temperature-gated ion channel activity | molecular function | Enables the transmembrane transfer of an ion by a channel that opens in response to a temperature stimulus (e.g. exposure to a temperature range different than the optimal temperature for that organism). [GOC:ha, GOC:pr, PMID:23027824] |
Located In
This protein is located in 6 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
external side of plasma membrane | cellular component | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. [GOC:dos, GOC:tb] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
dendritic spine membrane | cellular component | The portion of the plasma membrane surrounding a dendritic spine. [GOC:mah] |
neuronal cell body | cellular component | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. [GOC:go_curators] |
postsynaptic membrane | cellular component | A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. [ISBN:0198506732] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Involved In
This protein is involved in 36 target(s):
Target | Category | Definition |
negative regulation of transcription by RNA polymerase II | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |
fever generation | biological process | The heat generation process that results in a rise in body temperature above the normal, often as a response to infection. [GOC:dph, GOC:jl] |
microglial cell activation | biological process | The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. [GOC:mgi_curators, PMID:10626665, PMID:10695728, PMID:12580336, PMID:9893949] |
diet induced thermogenesis | biological process | The process that results in increased metabolic rate in tissues of an organism. It is triggered by the detection of dietary excess. This process is achieved via signaling in the sympathetic nervous system. [PMID:12161655] |
peptide secretion | biological process | The controlled release of a peptide from a cell or a tissue. [GOC:add] |
negative regulation of systemic arterial blood pressure | biological process | The process that reduces the force with which blood travels through the systemic arterial circulatory system. [GOC:mtg_cardio] |
lipid metabolic process | biological process | The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids. [GOC:ma] |
cell surface receptor signaling pathway | biological process | The series of molecular signals initiated by an extracellular ligand binding to a receptor located on the cell surface. The pathway ends with regulation of a downstream cellular process, e.g. transcription. [GOC:signaling] |
positive regulation of cytosolic calcium ion concentration | biological process | Any process that increases the concentration of calcium ions in the cytosol. [GOC:ai] |
chemosensory behavior | biological process | Behavior that is dependent upon the sensation of chemicals. [GOC:go_curators] |
negative regulation of heart rate | biological process | Any process that stops, prevents or reduces the frequency or rate of heart contraction. [GOC:dph, GOC:tb] |
negative regulation of mitochondrial membrane potential | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or extent of a mitochondrial membrane potential, the electric potential existing across any mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. [GOC:dph, GOC:tb] |
glutamate secretion | biological process | The controlled release of glutamate by a cell. The glutamate is the most abundant excitatory neurotransmitter in the nervous system. [GOC:ef] |
calcium-mediated signaling | biological process | Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions. [GOC:signaling] |
cellular response to heat | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. [GOC:mah] |
positive regulation of apoptotic process | biological process | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
response to peptide hormone | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals. [PMID:11027914, PMID:15134857, Wikipedia:Peptide_hormone] |
positive regulation of nitric oxide biosynthetic process | biological process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. [GOC:go_curators] |
behavioral response to pain | biological process | Any process that results in a change in the behavior of an organism as a result of a pain stimulus. Pain stimuli cause activation of nociceptors, peripheral receptors for pain, include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli. [GOC:jid] |
sensory perception of mechanical stimulus | biological process | The series of events required for an organism to receive a sensory mechanical stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process. [GOC:ai] |
detection of temperature stimulus involved in thermoception | biological process | The series of events in which a temperature stimulus is received and converted into a molecular signal as part of thermoception. [GOC:ai, GOC:dos] |
detection of temperature stimulus involved in sensory perception of pain | biological process | The series of events involved in the perception of pain in which a temperature stimulus is received and converted into a molecular signal. [GOC:ai, GOC:dos] |
detection of chemical stimulus involved in sensory perception of pain | biological process | The series of events involved in the perception of pain in which a chemical stimulus is received and converted into a molecular signal. [GOC:ai] |
protein homotetramerization | biological process | The formation of a protein homotetramer, a macromolecular structure consisting of four noncovalently associated identical subunits. [GOC:go_curators] |
excitatory postsynaptic potential | biological process | A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. [GOC:dph, GOC:ef] |
smooth muscle contraction involved in micturition | biological process | The process leading to shortening and/or development of tension in the urinary bladder smooth muscle tissue involved in the expulsion urine from the body. [GOC:dph, PMID:15827347] |
calcium ion transmembrane transport | biological process | A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. [GOC:mah] |
cellular response to alkaloid | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active. [GOC:mah] |
cellular response to ATP | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus. [GOC:mah] |
cellular response to tumor necrosis factor | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. [GOC:mah] |
cellular response to acidic pH | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus with pH < 7. pH is a measure of the acidity or basicity of an aqueous solution. [GOC:go_curators, GOC:mah, Wikipedia:PH] |
cellular response to temperature stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus. [GOC:mah] |
negative regulation of establishment of blood-brain barrier | biological process | Any process that decreases the rate, frequency or extent of the establishment of the blood-brain barrier, a selectively permeable structural and functional barrier that exists between the capillaries and the brain. [GOC:dph, GOC:tb] |
calcium ion import across plasma membrane | biological process | The directed movement of calcium ions from outside of a cell, across the plasma membrane and into the cytosol. [GOC:dos] |
response to capsazepine | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a capsazepine stimulus. [GOC:TermGenie] |
cellular response to nerve growth factor stimulus | biological process | A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus. [PMID:22399805, Wikipedia:Nerve_growth_factor] |